About Iceni Glycoscience
Iceni Glycoscience is a company based in Norwich (United Kingdom) founded in 2014 by Rob Field and David Russell.. Iceni Glycoscience has raised $1.77 million across 7 funding rounds from investors including European Union and New Anglia Local Enterprise Partnership. Iceni Glycoscience offers products and services including Contract Services and Analytical Services. Iceni Glycoscience operates in a competitive market with competitors including GlyTech, Echelon Biosciences, GlycoSpot, TFChem and ADDAX Biosciences, among others.
- Headquarter Norwich, United Kingdom
- Founders Rob Field, David Russell
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Iceni Diagnostics Limited
- Date of Incorporation 02 Aug, 2021
- Jurisdiction COLCHESTER, ESSEX, ENGLAND
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$1.77 M (USD)
in 7 rounds
-
Latest Funding Round
$365.09 K (USD), Grant
Mar 01, 2021
-
Investors
European Union
& 1 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Iceni Glycoscience
Iceni Glycoscience offers a comprehensive portfolio of products and services, including Contract Services and Analytical Services. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Offers carbohydrate chemistry for diagnostics and therapeutics.
Provides glycobiology analysis for pharma and research.
Funding Insights of Iceni Glycoscience
Iceni Glycoscience has successfully raised a total of $1.77M across 7 strategic funding rounds. The most recent funding activity was a Grant round of $365.09 thousand completed in March 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 7
- Last Round Grant — $365,091
- First Round First Round
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar, 2021 | Amount | Grant - Iceni Glycoscience | Valuation |
investors |
|
| Jan, 2021 | Amount | Seed - Iceni Glycoscience | Valuation | New Anglia Local Enterprise Partnership |
|
| Jun, 2020 | Amount | Grant - Iceni Glycoscience | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Iceni Glycoscience
Iceni Glycoscience has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include European Union and New Anglia Local Enterprise Partnership. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Founded Year | Domain | Location | |
|
A government agency focused on the economic development of Norfolk and Suffolk regions.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Iceni Glycoscience
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Iceni Glycoscience
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Iceni Glycoscience Comparisons
Competitors of Iceni Glycoscience
Iceni Glycoscience operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as GlyTech, Echelon Biosciences, GlycoSpot, TFChem and ADDAX Biosciences, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Human-type Asp-linked glycans are supplied for research applications.
|
|
| domain | founded_year | HQ Location |
Reagents and assays for lipid biology research are manufactured.
|
|
| domain | founded_year | HQ Location |
High-throughput enzyme screening solutions are developed and provided.
|
|
| domain | founded_year | HQ Location |
Fluoride chemistry is utilized to design glycomimetic drug compounds.
|
|
| domain | founded_year | HQ Location |
Developer of a non-toxic formalin alternative tissue fixative. This fixative provides comparable or superior results to formalin in histological, immunohistochemical, and molecular analyses, while eliminating the carcinogenic and toxic risks associated with formalin use. The product is protected by an international patent and is designed for use in histology laboratories, improving both patient care and worker safety. The company collaborates with various research institutions to advance the application of this technology in different fields.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Iceni Glycoscience
Frequently Asked Questions about Iceni Glycoscience
When was Iceni Glycoscience founded?
Iceni Glycoscience was founded in 2014 and raised its 1st funding round 4 years after it was founded.
Where is Iceni Glycoscience located?
Iceni Glycoscience is headquartered in Norwich, United Kingdom. It is registered at Norwich, Norfolk, United Kingdom.
Who is the current CEO of Iceni Glycoscience?
Martin Stocks is the current CEO of Iceni Glycoscience.
Is Iceni Glycoscience a funded company?
Iceni Glycoscience is a funded company, having raised a total of $1.77M across 7 funding rounds to date. The company's 1st funding round was a Grant of $62.39K, raised on Jan 10, 2018.
What does Iceni Glycoscience do?
Iceni Glycoscience was founded in 2014 in Norwich, United Kingdom, within the biotechnology sector. A platform based on glycoscience is offered for applications in diagnostics and therapeutics. Host-pathogen glycan recognition technology is employed to create carbohydrate-based probes. These probes are used to advance diagnostics, therapeutics, and vaccines against respiratory pathogens, including human, avian, and equine influenza, coronavirus, norovirus, and rotavirus.
Who are the top competitors of Iceni Glycoscience?
Iceni Glycoscience's top competitors include GlyTech, Echelon Biosciences and GlycoSpot.
What products or services does Iceni Glycoscience offer?
Iceni Glycoscience offers Contract Services and Analytical Services.
Who are Iceni Glycoscience's investors?
Iceni Glycoscience has 2 investors. Key investors include European Union, and New Anglia Local Enterprise Partnership.